Truvian Sciences Raises $105M for Near-Patient Lab Test System

By Robert Michel | From the Volume XXVIII, No. 4 – March 22, 2021 Issue

DESPITE THE PANDEMIC, investors continue to support emerging in vitro diagnostics (IVD) companies. This is particularly true of start-up companies that want to develop clinical lab testing systems that can be used at the point of care, that require small amounts of blood, and that deliver accu…

Read More

---

NEWSMAKER INTERVIEW: Ralph Taylor, CEO of Sysmex America

By R. Lewis Dark | From the Volume XXV No. 3 – February 12, 2018 Issue

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures. Core laboratories have something unique and irreplacea…

Read More

---

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry

By Joseph Burns | From the Volume XXV No. 3 – February 12, 2018 Issue

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.” …

Read More

---

FDA CLEARS WAIVED CBC FOR NEAR-PATIENT TESTING

By R. Lewis Dark | From the Volume XXIV No. 16 – November 20, 2017 Issue

CEO SUMMARY: Market clearance of the first-ever CLIA waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer …

Read More

---

Docs’ In-Office Testing Showing Mixed Trends

By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue

CEO SUMMARY: Despite the burdens of CLIA certification and reduced reimbursement for lab tests, many medical practice experts are advising doctors to expand in-office testing. However, diagnostic technologies for near-patient testing are still not robust enough to support this trend. Earl…

Read More

---

Nurse Shortage Parallels That of Fewer Med Techs

By Robert Michel | From the Volume VIII No. 3 – February 26, 2001 Issue

CEO SUMMARY: It’s a story that will soon become a national headline. Even as laboratories struggle to find enough med techs to fill open positions, hospitals are facing an even bigger problem in getting enough nurses to keep units staffed and open. Recruiting nurses overseas is one solu…

Read More

---

Management Execution Makes a Difference

By R. Lewis Dark | From the Volume VII No. 14 – October 2, 2000 Issue

THERE’S PLENTY OF HOOROAR AND EXCITEMENT about skyrocketing stock prices for several public lab and pathology companies in 2000! But this crusty old curmudgeon has been around the investment industry too long to accept Wall Street’s new-found enthusiasm for clinical laboratories as definitive pr…

Read More

---

Qualigen’s POL PSA Test Cleared for Sale by FDA

By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue

CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…

Read More

---

“State of Lab Industry” Reveals Radical Change

By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue

CEO SUMMARY: Pick your trend: declining reimbursement, consolidation, clinical integration, downsizing, and capitated reimbursement. These trends all continued to shape the way laboratories organized to provide services. But 1997’s wildcard was the federal government. Between investigat…

Read More

---

Joint Venture In Phoenix To Be Copied Elsewhere

By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue

CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…

Read More

---